back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-25 15:18 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2026-03-25 14:59 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2026-03-25 14:59 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-25 14:58 Tx date 2024-06-06 |
$PCRX
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Holder: JDUMONT005 (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-25 08:58 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$14,900
+29,800 vol $0.50 each |
29,800 | |
| Filed 2026-03-25 08:57 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$29,762
+59,525 vol $0.50 each |
59,525 | |
| Filed 2026-03-25 08:55 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$25,032
+59,600 vol $0.42 each |
59,600 | |
| Filed 2026-03-25 08:51 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$50,001
+119,050 vol $0.42 each |
369,050 | |
| Filed 2025-11-14 15:02 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$14,881
+29,762 vol $0.50 each |
||
| Filed 2025-11-14 15:00 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$25,000
+59,524 vol $0.42 each |
||
| Filed 2025-11-14 14:57 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 14:57 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 14:56 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$44,662
+89,325 vol $0.50 each |
||
| Filed 2025-11-14 14:53 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$75,033
+178,650 vol $0.42 each |
||
| Filed 2024-06-11 10:18 Tx date 2024-06-06 |
$PCRX
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Holder: JDUMONT005 (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-04 16:19 Tx date 2026-03-03 |
$PCRX
PharmaCorp Rx Inc. |
Tatchell, Terri Jean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,763
+19,916 vol $0.44 each |
521,077 | |
| Filed 2026-03-04 16:17 Tx date 2026-03-03 |
$PCRX
PharmaCorp Rx Inc. |
LeRoux, Calvin Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,799
+13,180 vol $0.44 each |
482,637 | |
| Filed 2026-03-04 16:15 Tx date 2026-03-03 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,661
+87,868 vol $0.44 each |
385,368 | |
| Filed 2026-03-04 16:13 Tx date 2026-03-03 |
$PCRX
PharmaCorp Rx Inc. |
Brown, Grady Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$19,330
+43,934 vol $0.44 each |
942,007 | |
| Filed 2026-03-04 16:11 Tx date 2026-03-03 |
$PCRX
PharmaCorp Rx Inc. |
Simpson, Alan Arthur
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,928
+13,473 vol $0.44 each |
3,140,765 | |
| Filed 2026-01-22 10:02 Tx date 2026-01-22 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-70,652 vol |
297,500 | |
| Filed 2026-01-02 18:19 Tx date 2025-12-31 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,250
+13,587 vol $0.46 each |
87,327 | |
| Filed 2026-01-02 13:31 Tx date 2025-12-31 |
$PCRX
PharmaCorp Rx Inc. |
Simpson, Alan Arthur
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$28,750
+62,500 vol $0.46 each |
3,127,292 | |
| Filed 2026-01-02 13:12 Tx date 2025-12-31 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,250
+13,587 vol $0.46 each |
87,327 | |
| Filed 2026-01-02 13:10 Tx date 2025-12-31 |
$PCRX
PharmaCorp Rx Inc. |
Fradette, Glenn Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,250
+17,935 vol $0.46 each |
691,685 | |
| Filed 2026-01-02 13:08 Tx date 2025-12-31 |
$PCRX
PharmaCorp Rx Inc. |
Tatchell, Terri Jean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,250
+46,196 vol $0.46 each |
501,161 | |
| Filed 2026-01-02 13:06 Tx date 2025-12-31 |
$PCRX
PharmaCorp Rx Inc. |
LeRoux, Calvin Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,249
+35,326 vol $0.46 each |
469,457 | |
| Filed 2026-01-02 13:04 Tx date 2025-12-31 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,499
+70,652 vol $0.46 each |
368,152 | |
| Filed 2026-01-02 13:01 Tx date 2025-12-31 |
$PCRX
PharmaCorp Rx Inc. |
Carroll, Kimberly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,500
+11,957 vol $0.46 each |
1,627,790 | |
| Filed 2026-01-02 12:59 Tx date 2025-12-31 |
$PCRX
PharmaCorp Rx Inc. |
Brownell, Kenneth Alva
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,250
+13,587 vol $0.46 each |
87,327 | |
| Filed 2026-01-02 12:56 Tx date 2025-12-31 |
$PCRX
PharmaCorp Rx Inc. |
Brown, Grady Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,250
+67,935 vol $0.46 each |
898,073 | |
| Filed 2025-11-14 15:02 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$14,881
+29,762 vol $0.50 each |
29,762 | |
| Filed 2025-11-14 15:01 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 15:00 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$25,000
+59,524 vol $0.42 each |
59,524 | |
| Filed 2025-11-14 14:57 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 14:56 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$44,662
+89,325 vol $0.50 each |
89,325 | |
| Filed 2025-11-14 14:55 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 14:53 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$75,033
+178,650 vol $0.42 each |
428,650 | |
| Filed 2025-11-14 14:46 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Simpson, Alan Arthur
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$595,240
+1,190,480 vol $0.50 each |
1,190,480 | |
| Filed 2025-11-14 14:45 Tx date 2022-04-06 |
$PCRX
PharmaCorp Rx Inc. |
Simpson, Alan Arthur
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 14:43 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Simpson, Alan Arthur
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$1,000,003
+2,380,960 vol $0.42 each |
4,880,960 | |
| Filed 2025-11-13 19:31 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Holder: Elixir Holding Company Ltd. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$14,875
+29,750 vol $0.50 each |
29,750 | |
| Filed 2025-11-13 19:30 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Holder: Elixir Holding Company Ltd. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-13 19:28 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Holder: Elixir Holding Company Ltd. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$24,990
+59,500 vol $0.42 each |
559,500 | |
| Filed 2025-11-13 19:27 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$17,877
+35,755 vol $0.50 each |
35,755 | |
| Filed 2025-11-13 19:26 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-13 19:25 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$30,034
+71,510 vol $0.42 each |
71,510 | |
| Filed 2025-11-13 19:24 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-13 19:22 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$59,525
+119,050 vol $0.50 each |
119,050 | |
| Filed 2025-11-13 19:21 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-13 19:20 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,002
+238,100 vol $0.42 each |
238,100 | |
| Filed 2025-11-13 19:17 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Brown, Grady Douglas
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$148,810
+297,620 vol $0.50 each |
297,620 | |
| Filed 2025-11-13 19:16 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Brown, Grady Douglas
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-13 19:14 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Brown, Grady Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$250,000
+595,240 vol $0.42 each |
907,740 | |
| Filed 2025-11-13 19:12 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Brownell, Kenneth Alva
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$59,500
+119,000 vol $0.50 each |
119,000 | |
| Filed 2025-11-13 19:05 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Brownell, Kenneth Alva
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-13 19:03 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Brownell, Kenneth Alva
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$99,960
+238,000 vol $0.42 each |
609,900 | |
| Filed 2025-11-12 15:52 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-12 15:23 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-07-06 16:18 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-33,854 vol |
297,500 | |
| Filed 2025-07-03 11:31 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,999
+52,083 vol $0.48 each |
73,740 | |
| Filed 2025-07-03 11:26 Tx date 2024-07-18 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,662
+21,657 vol $0.40 each |
21,657 | |
| Filed 2025-07-03 11:23 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-07-03 11:22 Tx date 2024-07-18 |
$PCRX
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$8,626
+21,567 vol $0.40 each |
||
| Filed 2025-07-03 10:22 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Carroll, Kimberly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,999
+45,833 vol $0.48 each |
1,615,833 | |
| Filed 2024-07-18 13:54 Tx date 2024-07-18 |
$PCRX
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$8,626
+21,567 vol $0.40 each |
||
| Filed 2025-07-02 17:18 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Simpson, Alan Arthur
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$57,500
+119,792 vol $0.48 each |
3,064,792 | |
| Filed 2025-07-02 17:12 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,999
+52,083 vol $0.48 each |
73,740 | |
| Filed 2025-07-02 17:10 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Brownell, Kenneth Alva
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,999
+52,083 vol $0.48 each |
73,740 | |
| Filed 2025-07-02 17:08 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Fradette, Glenn Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,000
+68,750 vol $0.48 each |
673,750 | |
| Filed 2025-07-02 17:06 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Tatchell, Terri Jean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$42,500
+88,542 vol $0.48 each |
454,965 | |
| Filed 2025-07-02 17:04 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,249
+33,854 vol $0.48 each |
331,354 | |
| Filed 2025-07-02 17:02 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
LeRoux, Calvin Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,499
+67,708 vol $0.48 each |
434,131 | |
| Filed 2025-07-02 17:00 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Brown, Grady Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$62,499
+130,208 vol $0.48 each |
830,138 | |
| Filed 2024-09-05 19:44 Tx date 2024-08-27 |
$PCRX
PharmaCorp Rx Inc. |
Amy, Krista Michelle
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: 102031365 Saskatchewan Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
910,025 | ||
| Filed 2024-09-05 19:39 Tx date 2024-08-27 |
$PCRX
PharmaCorp Rx Inc. |
Amy, Krista Michelle
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
62,500 |